grant
Long-term Cardiometabolic Disease in COVID-19
Organization ST. LOUIS VA MEDICAL CENTERLocation St. Louis, UNITED STATESPosted 1 Oct 2025Deadline 30 Sept 2029
VANIHUS FederalResearch GrantFY20252019 novel corona virus2019 novel coronavirus2019-nCoV2019-nCoV vaccine2019-nCoV variant2019-nCoV variant forms2019-nCoV variant strainsActive Follow-upAcuteAddressAlgorithmsBenchmarkingBest Practice AnalysisCOVID testCOVID testsCOVID-19COVID-19 affectedCOVID-19 consequenceCOVID-19 effectCOVID-19 exposureCOVID-19 impactCOVID-19 impactedCOVID-19 related riskCOVID-19 riskCOVID-19 risk factorCOVID-19 testCOVID-19 testsCOVID-19 vaccinationCOVID-19 vaccineCOVID-19 variantCOVID-19 variant formsCOVID-19 variant strainsCOVID-19 virusCOVID19 virusCV-19Cardiometabolic DiseaseCardiometabolic DisorderCardiovascular DiseasesCaringCessation of lifeCharacteristicsCoV-2CoV2Coronavirus Infectious Disease 2019DataDeathDiabetes MellitusDiagnosisDoseDyslipidemiasEffectivenessElectronic Health RecordEnrollmentEquilibriumEventFederal GovernmentFutureGrippeHealthHealth CareHealth Insurance for Aged and Disabled, Title 18Health Insurance for Disabled Title 18Health PolicyHistoryHospital AdmissionHospitalizationIncidenceIndividualInfectionInfluenzaInterest GroupKidney DiseasesKnowledgeLaboratoriesLong COVIDLong COVID-19Long coronavirus diseaseLong coronavirus disease 2019Long-term Follow-upMedicareMethodologyModelingNational GovernmentNephropathyOutcomePatientsPersonsPoliciesProbabilityProxyPublic HealthRecording of previous eventsRenal DiseaseReportingResearchRiskRisk ReductionRoleSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV-2 exposureSARS-CoV-2 testSARS-CoV-2 testsSARS-CoV-2 vaccinationSARS-CoV-2 vaccineSARS-CoV-2 variantSARS-CoV-2 variant formsSARS-CoV-2 variant strainsSARS-CoV2SARS-CoV2 exposureSARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-coronavirus-2 vaccineSARS-related corona virus 2SARS-related coronavirus 2SARSCoV2Severe Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome CoV 2 vaccineSevere Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome coronavirus 2 exposureSevere acute respiratory syndrome coronavirus 2 vaccinationSevere acute respiratory syndrome coronavirus 2 vaccineSevere acute respiratory syndrome related corona virus 2Test ResultTestingTimeTitle 18United States Department of Veterans AffairsUnited States Veterans AdministrationVaccinationVaccinesVariantVariationVeterans AdministrationVeterans AffairsWeightWuhan coronavirusactive followupacute COVID-19acute SARS-CoV-2 infectionacute phase of COVID-19acute phase of SARS-CoV-2 infectionadverse consequenceadverse event riskadverse outcomeassess effectivenessbalancebalance functionbenchmarkcardiometaboliccardiometabolic riskcardiometabolismcardiovascular disorderchronic COVIDchronic COVID-19chronic novel coronavirus disease 2019clinical careclinical epidemiologycohortcomparativecoronavirus disease 2019coronavirus disease 2019 consequencecoronavirus disease 2019 effectcoronavirus disease 2019 exposurecoronavirus disease 2019 impactcoronavirus disease 2019 riskcoronavirus disease 2019 risk factorcoronavirus disease 2019 testcoronavirus disease 2019 testscoronavirus disease 2019 vaccinationcoronavirus disease 2019 vaccinecoronavirus disease 2019 variantcoronavirus disease 2019 variant formscoronavirus disease 2019 variant strainscoronavirus disease 2019 viruscoronavirus disease testcoronavirus disease testscoronavirus disease-19coronavirus disease-19 impactcoronavirus disease-19 vaccinecoronavirus disease-19 viruscoronavirus infectious disease-19coronavirus testcoronavirus testsdata sharing networksdata sharing resourcedeath riskdesigndesigningdetermine effectivenessdiabeteseffectiveness assessmenteffectiveness evaluationelectronic health care recordelectronic health medical recordelectronic health plan recordelectronic health registryelectronic medical health recordenrollevaluate effectivenessevidence baseexamine effectivenessexposure to COVID-19exposure to SARS-CoV-2exposure to SARS-CoV2exposure to Severe acute respiratory syndrome coronavirus 2exposure to coronavirus disease 2019follow upfollow-upfollowed upfollowuphCoV19hazardhealth care policyhealth insurance for disabledhistoriesinnovateinnovationinnovativekidney disorderlong haul COVIDlong haul COVID-19long haul coronavirus diseaselong haul coronavirus disease 2019long-hauler COVIDlong-hauler COVID-19long-hauler coronavirus disease 2019long-hauler syndromelong-term COVIDlong-term COVID-19long-term coronavirus diseaselong-term coronavirus disease 2019long-term followupmortality risknCoV vaccinenCoV-19 vaccinenCoV19 vaccinenCoV2pandemicpandemic diseasepersistent COVID-19post COVID syndromepost COVID-19 syndromepost acute COVID syndromepost acute COVID-19post acute COVID-19 syndromepost acute SARS-CoV-2post acute coronavirus disease 2019post acute coronavirus disease 2019 syndromepost acute coronavirus disease syndromepost acute severe acute respiratory syndrome coronavirus 2post coronavirus disease 2019 syndromepost coronavirus disease syndromepost-acute phases of COVID-19prolonged COVID-19 symptomsreduce riskreduce risksreduce that riskreduce the riskreduce these risksreduces riskreduces the riskreducing riskreducing the riskrenal disorderrisk associated with COVID-19risk factor associated with COVID-19risk factor related to COVID-19risk related to COVID-19risk-reducingseasonal fluseasonal influenzasevere acute respiratory syndrome coronavirus 2 testsevere acute respiratory syndrome coronavirus 2 testssevere acute respiratory syndrome coronavirus 2 variantsevere acute respiratory syndrome coronavirus 2 variant formssevere acute respiratory syndrome coronavirus 2 variant strainssocial roletest for COVIDvaccinate against COVID-19vaccinate against SARS-CoV-2vaccinate against coronavirus disease 2019vaccinate against severe acute respiratory syndrome coronavirus 2vaccination against COVID-19vaccination against SARS-CoV-2vaccination against Severe acute respiratory syndrome coronavirus 2vaccination against coronavirus disease 2019vaccine against 2019-nCovvaccine against COVID-19vaccine against SARS-CoV-2vaccine against SARS-coronavirus-2vaccine against Severe Acute Respiratory Syndrome CoV 2vaccine against Severe acute respiratory syndrome coronavirus 2vaccine candidates against SARS-CoV-2vaccine for novel coronavirusvaccines preventing COVIDvaccines to prevent COVIDweights
Description preview
Background: People with COVID-19 have increased risk of death and cardiometabolic disease including
cardiovascular disease, diabetes mellitus, dyslipidemia and kidney disease. However, the evidence base
is limited in 3 key aspects: (1) Existing studies have characterized the risks of adverse outcomes associated
with earlier variants of SARS-CoV-2…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click